Legal Implications of AI in Pharmaceutical Decision-Making
Abstract
The integration of artificial intelligence (AI) in pharmaceutical decision-making has revolutionized drug discovery, clinical trials, regulatory compliance, and patient care. However, AI implementation raises critical legal and ethical concerns, including liability, intellectual property rights, data privacy, and regulatory compliance. This paper explores the legal implications of AI in pharmaceutical decision-making, focusing on existing frameworks and challenges. It highlights the necessity for robust legal structures to address AI-related risks while promoting innovation.
How to Cite This Article
Adriane Fugh-Berman (2025). Legal Implications of AI in Pharmaceutical Decision-Making . Journal of Frontiers in Multidisciplinary Research (JFMR), 6(1), 09-10.